LLAI — LungLife AI Balance Sheet
0.000.00%
- £0.69m
- -£1.12m
- $0.05m
Annual balance sheet for LungLife AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 0.128 | 14.6 | 8.01 | 2.83 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0 | 0.049 | 0.15 | 0.175 |
Prepaid Expenses | ||||
Total Current Assets | 0.297 | 15.4 | 8.62 | 3.3 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.463 | 0.766 | 0.566 | 0.389 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Total Assets | 0.774 | 22 | 15 | 9.52 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 11.9 | 1.19 | 1.48 | 1.45 |
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 12.1 | 1.84 | 1.88 | 1.61 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | -11.3 | 20.1 | 13.1 | 7.91 |
Total Liabilities & Shareholders' Equity | 0.774 | 22 | 15 | 9.52 |
Total Common Shares Outstanding |